Institutional Ownership Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX). We have compiled data on the 206 institutions that hold shares in the stock, with a total of 85 Million shares, which have been reported (via 13F filing form) to have a value of $1.97 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
7,648,000
shares
|
$181 Million
1.78% of portfolio
|
Q3 2024
Added 1.97%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,644,789
shares
|
$181 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.95%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,742,165
shares
|
$160 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.32%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
4,684,476
shares
|
$111 Million
2.23% of portfolio
|
Q3 2024
Added 4.51%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
4,340,340
shares
|
$103 Million
0.55% of portfolio
|
Q3 2024
Added 239.92%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
4,272,914
shares
|
$101 Million
0.07% of portfolio
|
Q3 2024
Reduced 2.17%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,736,696
shares
|
$64.9 Million
0.0% of portfolio
|
Q3 2024
Reduced 22.05%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,409,514
shares
|
$57.2 Million
0.07% of portfolio
|
Q4 2024
Added 28.51%
|
|
|
Emerald Advisers, LLC
|
Feb 11, 2025 Q4 2024 |
2,125,744
shares
|
$50.4 Million
1.57% of portfolio
|
Q4 2024
Added 8.42%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,957,120
shares
|
$46.4 Million
0.04% of portfolio
|
Q2 2023
Added 26.22%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,842,301
shares
|
$43.7 Million
0.0% of portfolio
|
Q4 2024
Added 6.43%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,840,069
shares
|
$43.6 Million
0.02% of portfolio
|
Q3 2024
Added 20.02%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,832,103
shares
|
$43.5 Million
0.01% of portfolio
|
Q3 2024
Added 148.37%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
1,714,620
shares
|
$40.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.75%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
1,590,377
shares
|
$37.7 Million
0.09% of portfolio
|
Q3 2024
Reduced 15.85%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2024 Q3 2024 |
1,371,511
shares
|
$32.5 Million
1.57% of portfolio
|
Q3 2024
Reduced 32.16%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,349,408
shares
|
$32 Million
0.0% of portfolio
|
Q3 2024
Reduced 61.33%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,285,379
shares
|
$30.5 Million
0.03% of portfolio
|
Q3 2024
New holding
|
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 29, 2024 Q3 2024 |
1,185,709
shares
|
$28.1 Million
0.94% of portfolio
|
Q3 2024
Added 25.97%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,100,000
shares
|
$26.1 Million
2.04% of portfolio
|
Q3 2024
New holding
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
1,086,067
shares
|
$25.8 Million
2.15% of portfolio
|
Q3 2024
Added 11.98%
|
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
969,141
shares
|
$23 Million
0.02% of portfolio
|
Q4 2024
Added 60.47%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
931,012
shares
|
$22.1 Million
0.0% of portfolio
|
Q4 2024
Added 32.51%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
869,913
shares
|
$20.6 Million
0.96% of portfolio
|
Q3 2024
Reduced 20.28%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
858,942
shares
|
$20.4 Million
0.0% of portfolio
|
Q4 2024
Added 135.19%
|